Skip to main content

Table 3 Neuroalgological, functional and hystopathological data at Tx

From: Chronic pain in Gaucher disease: skeletal or neuropathic origin?

Patient

No.

Sex

M/F

ERT duration (yrs)

NPSI*

NRS

(0–10)

QST at dorsal foot

Z score

IENF/mm

(lower limit of normality)

Q1

Q10

Q11

Q12

WDT

CDT

PHS

MDT

PPT

DL

Pth

1

F

20

5

5

0

0

+2.6

−3.9

+3.8

−2.5

−0.1

6.2 (7.1)

3.2 (14.3)

2*

M

0

−

−

−

−

+2.1

−3.3

+2.9

−3.1

−0.3

−

−

3

F

17

−

−

−

−

+2.3

−3.5

+2.8

−2.8

−0.1

3.8 (5.7)

6.6 (14.0)

4

M

15

−

−

−

−

+2.4

−3.1

+3.1

−3.4

−0.3

6.8 (10.9)

3.1(16.4)

5

M

19

7

6

0

5

+1.9

−3.3

+3.3

−2.5

−0.2

0.8 (3.5)

6.2 (13.5)

6

F

19

−

−

−

−

+1.6

−3.3

+2.9

−2.6

+2.8

−

−

7

F

21

0

7

6

0

+2.1

−2.8

+2.8

−2.9

−0.2

−

−

8

M

21

0

2

0

7

+2.3

−2.6

+2.8

−3.1

+3.1

8.5 (5.2)

7.8 (14.1)

9

F

22

−

−

−

−

+2.4

−3.0

+2.2

−2.8

−0.4

0.6 (7.1)

0.9 (14.3)

10

M

17

−

−

−

−

−

−

−

−

−

4.4 (3.5)

6.5 (13.5)

11

F

17

−

−

−

−

−

−

−

−

−

4.4 (5.7)

7.2 (14.0)

12

M

17

5.5

5

0

0

+2.6

−2.7

+2.4

−2.5

+3.1

5.2 (4.4)

6.2 (13.8)

13

M

11

6

5

3

6

−

−

−

−

−

8.2 (2.8)

20.0 (11.2)

14

M

14

    

+2.7

−3.3

+2.7

−2.4

−0.3

−

−

15

F

14

7

2

4

0

−

−

−

−

−

8.2 (4.3)

7.3 (13.8)

16*

F

0

8

5

7

0

+2.8

−3.8

+2.6

−2.6

+3.4

2.8 (7.1)

4.6 (14.3)

17

F

17

10

4

6

0

+2.6

−3.1

+3.1

−2.8

+2.8

9.8 (4.3)

9.6 (13.8)

18

F

13

8

6

7

5

+2.7

−3.9

+3.0

−2.7

+3.2

7.2 (5.7)

13.0 (14.0)

19

M

13

0

0

0

0

−

−

−

−

−

3.8 (6.1)

17.5 (16.4)

20**

M

11

6

4

0

4

+2.8

−3.2

+2.1

−3.1

+0.2

6.2 (3.5)

9.8 (13.5)

21

F

18

5

1

0

7

−

−

−

−

−

6.0 (5.7)

9.9 (14.0)

22

M

19

−

−

−

−

−

−

−

−

−

3.7 (5.7)

7.6 (13.8)

23

F

20

−

−

−

−

+2.6

−3.1

+2.9

−3.2

−0.1

7.5 (5.7)

5.2 (14.0)

24*

F

0

5

3

0

0

+2.5

−3.6

+2.7

−3.0

+0.3

1.0 (4.3)

2.5 (13.8)

25

M

20

−

−

−

−

−

−

−

−

−

5.2 (5.2)

6.2 (14.3)

  1. *Patients naïve to any therapy; ** Patient receiving SRT and ERT
  2. Neuroalgological findings. *NPSI: Q1, Q10, Q11, Q12 choose by relevance. Q1 examines spontaneous cooling/burning pain, Q10 pain evoked by cold, Q11 spontaneous pins pain and Q12 pareaesthesia
  3. Sensory thresholds (WDT, CDT, PHS, MDT) at QST refer to the dorsal foot and are reported as Z score. Values ±2.5 was considered abnormal
  4. IENF density (IENF/mm) was considered abnormal when it was below the 5th percentile of the normative database. Finding for distal leg were compared with international normative data for distal leg age stratified and for proximal sites with published normative data not age stratified and also 86 age and sex-matched healthy subjects from our Laboratory (not published). IENF densities at proximal thigh were the following: for females 13.5 ± 2.3 (range 9.8–16.3); males 12.8 ± 2.7 (range 8.6–16.4). In detail, the mean normal values age and sex-stratified for proximal thigh were for females: <19 yrs.: 16.3; 20-29 yrs.: 15.0; 30-39 yrs.: 14.3; 40-49 yrs.:14.0; 50-59 yrs.: 13.8; 60-69 yrs.: 11.8; 70-79 yrs.: 10.2; 80-89 yrs. 9.8. For males: <19 yrs.: 16.4; 20-29 yrs.: 15.2; 30-39 yrs.: 14.1; 40-49 yrs.:13.8; 50-59 yrs.: 13.5; 60-69 yrs.: 11.2; 70-79 yrs.: 9.8; 80-89 yrs.: 8.6